
Ancillary symptoms may be key in guiding treatment management for ADHD.
Here are 4 things to do when implementing a treatment strategy for tardive dyskinesia.
Comorbid bipolar disorder and ADHD: a big problem.
Here's how to have productive conversations with patients with tardive dyskinesia in order to improve outcomes.
How can we get back to recovery as the treatment goal for schizophrenia?
2024 into 2025: a period of highs and lows for schizophrenia treatment.
We're excited to preview our new upcoming partnership with the Psych NP Network at Real Psychiatry!
How has bipolar treatment changed over the past 40 years? The celebration of 40 years of Psychiatric Times continues at the Real Psychiatry conference.
Check out these top tips for treating postpartum depression from the Real Psychiatry conference!
The top 3 issues in treating bipolar disorder are...
We've upgraded our phones and computers... is it time to upgrade our psychiatric medications?
Carmen Kosicek, MSN, PMHNP-BC, is ready to teach nurse practitioners and advanced providers in a fun, innovative way at Real Psychiatry in Scottsdale, AZ.
Are you attending Real Psychiatry this weekend?
DLX-001 is a novel neuroplastogen under development for the treatment of major depressive disorder. Learn more about the latest phase 1 data here.
Do lifestyle interventions really work in Alzheimer disease and what are the underlying mechanisms? Learn more in this ACNP 2024 Annual Meeting session!
In highlighting recent advances and fostering collaboration and networking, the ACNP Annual Meeting helps usher in 2025 with hope and positivity.
While complete abstinence is a good goal, what other clinically meaningful endpoints are there for patients with substance use disorders? Learn more in this ACNP 2024 Annual Meeting session!
Previewing the 63rd ACNP Annual Meeting, which is set to highlight the latest research in psychiatry.
Are you attending Real Psychiatry in January?
Here's why you should attend Real Psychiatry!
Posters from Psych Congress confirm the durability of long-term treatment with xanomeline/trospium (Cobenfy).
An associate professor of family medicine shares more on her presentations at the Family Medicine Experience 2024.
A board-certified family and sports medicine physician who works with individuals with eating disorders shares her thoughts on the Family Medicine Experience 2024.
The 2024 American Society of Clinical Psychopharmacology Annual Meeting brought together researchers and clinicians to engage in discussion, education, and dissemination of research findings and new methodologies.
Additionally, 27% of US adults have reported they have a disability across a spectrum of areas.
Recent research found approximately 60 documented cases of suicidal ideation and 7 suicide attempts associated with semaglutide use in patients.
Cannabis withdrawal syndrome impacts approximately half of those who use it regularly. How can you help patients cease cannabis use?
Check out the latest results from the phase 3 CONNEX-X study.
In this Special Report, get the latest from the American Psychiatric Association Annual Meeting!